SPDL1 and ovarian carcinoma: Additionally, an unexpected and significant result was the utility of sPD-L1 in ovarian cancer, where it showed strong associations with tumor progression and poor prognosis, further highlighting its potential as a marker for risk stratification and therapeutic decision-making.